Rank #1893DSGN

Design Therapeutics, Inc.

$10.28

2.49% (Daily)

Market Cap

$585.59M

Revenue

$N/A

Rank by MCap

#1893

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Pratik Shah Ph.D.

Headquarters

Carlsbad, CA

Employees

About Design Therapeutics, Inc.

Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, pr...